Avoiding Costly IP Missteps: Insights for high-quality due diligence searches

por CAS, a division of the American Chemical Society

As chemical and life science companies seeking to monetize their IP portfolios emerge from the challenges of COVID-19, 2021 looks to be a year that will see increased product licensing, acquisitions a...

Leer más

Challenges in manufacturing high value lyophilized oncology drugs

por Telstar

A complete integrated freeze-drying system designed for high value anticancer products consisting of a reduced foot-print freeze dryer with an innovative loading/unloading system, integrating a steam-...

Leer más

OncoDNA announces expansion of its services into the United States

por OncoDNA

The theranostic and genomic company signs subcontract service agreement with HalioDx’s CLIA-certified laboratory in Richmond, Virginia

Leer más

American Hospital of Paris and OncoDNA Partner to Advance Breast Cancer Patients Management

por OncoDNA

American Hospital of Paris and OncoDNA announced a new joint initiative that is intended to advance the use of precision medicine in routine clinical practice for patients with metastatic breast cance...

Leer más

Maximizing the oncology production process

por Telstar

Telstar’s cutting-edge technologies and integrated process equipment & systems covering all the critical phases of the oncology production are designed according to the higher requirements of qualit...

Leer más

ONCODNA provides an update about the friendly takeover bid on INTEGRAGEN

por OncoDNA

OncoDNA SA has become the first shareholder of IntegraGen SA (Paris: ALINT), holding 29.99% of the existing shares, as result of purchases of shares on the Euronext Growth market .

Leer más

Agreement to file a friendly takeover bid initiated by OncoDNA on IntegraGen to acquire all outstanding shares at a price of 2.20€ per share

por OncoDNA

This transaction would bring together OncoDNA’s expertise in oncology precision medicine and IntegraGen’s know-how in DNA sequencing services and bioinformatics analyses. The combination of both c...

Leer más

Boehringer acquires Northern Biologics preclinical oncology pipeline

por CataloniaBio

Boehringer Ingelhe​im has acquired two preclinical antibodies from Canadian firm Nor​thern Biologics with the aim of further strengthening its global position in cancer immunology.

Leer más

ZeClinics joins the drug discovery and delivery network for oncology and eye therapeutics (3D-NEONET)

por ZeClinics

The consortium is bringing together a unique group of microbiologists, cancer biologists, chemists, material scientists, mechanical engineers, ocular pharmacologists, geneticists and toxicologists fro...

Leer más
Subscribirse al Directorio
Escribir un Artículo

Últimas Noticias

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Destacadas

Entrevista con Dámaso Molero, director ...

by 3P Biopharmaceuticals

Dámaso Molero:" Creo que en Latinoamérica habrá negocio en el d...

Minoryx presenta resultados de eficacia ...

by Minoryx Therapeutics

La biotecnológica Minoryx Therapeutics anuncia resultados positivos d...

Diapositiva de Fotos